Eventide Asset Management, LLC Ironwood Pharmaceuticals Inc Transaction History

Eventide Asset Management, LLC

  • $5.67 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$8.79 - $11.51 $6.51 Million - $8.52 Million
740,554 New
740,554 $8.47 Million
Q4 2018

Feb 14, 2019
SELL
$7.8 - $16.13 $1.5 Million - $3.1 Million
-192,000 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$12.07 - $14.87 $2.32 Million - $2.86 Million
192,000
192,000 $3.03 Million

Others Institutions Holding IRWD

# of Institutions
237
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $682M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email